InsidersTradesSigma
Follow the HUTCHMED (China) Ltd. share price and the full insider trade history of the company, a listed equity based in Hong Kong. Shares trade on the HK market, under the authority of HKEX. Market capitalisation: €1.8bn. The latest transaction was disclosed on 22 May 2026 (Purchase). Among the most active insiders: CHENG Chig Fung Johnny. Every trade is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
HUTCHMED (China) Ltd. es una empresa biofarmacéutica centrada en la investigación y el desarrollo de fármacos para el tratamiento del cáncer y enfermedades relacionadas con el sistema inmunitario. Tiene su sede en China y también opera a nivel internacional.